JORVEZA 0.5 mg, tablets orodispersible 90 tablets
Active ingredients: Budesonide
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JORVEZA 0,5 mg, comprimés orodispersibles
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 90 comprimé(s)
- Marketing authorisation holder
- FALK PHARMA
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Aug 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63330335CIP73025051CIP133400930250518Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUDÉSONIDEcomprimé | 0,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.